Skip to content

H.J. Res. 145 · 118th Congress (2023–2025)

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

CRS summary not yet available.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.J. Res. 145’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Brad Finstad (R-MN-1)
Cosponsors
6 cosponsors

1 original · 5 later

6 R

  1. Rep. Dan Crenshaw (R-TX-2)· Original · May 16, 2024
  2. Rep. Pete Sessions (R-TX-17)· Later · May 17, 2024
  3. Rep. Jefferson Van Drew (R-NJ-2)· Later · Jun 12, 2024
  4. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Jun 13, 2024
  5. Rep. Andy Biggs (R-AZ-5)· Later · Jul 5, 2024
  6. Rep. Neal P. Dunn (R-FL-2)· Later · Sep 27, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · May 16, 2024 – May 24, 2024
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred May 16, 2024
  2. HouseHealthReferred May 24, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

    Display title, Official title · Introduced in House